KCT0005674尚未招募未知
Diagnosis and Treatment of Dumping Syndrome Using Ambulatory Blood Glucose Level Monitoring in Gastrectomized patients
The Catholic University of Korea, Seoul St. Mary's Hospital0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 75(Year)（—）
- 性别
- All
入选标准
- •? Patients who underwent gastrectomy (including both total gastrectomy and subtotal gastrectomy) for gastric cancer
- •? Perform gastrectomy within 12 months from the time of study participation, more than 3 months
- •? Patients with abdominal pain or discomfort recurring at least 3 days per month in the past 3 months
排除标准
- •? Subjects who cannot use a smartphone
- •? If the skin is sensitive or has an allergic reaction
- •? Subjects who have received chemotherapy
- •? Subjects with a current or past history of inflammatory bowel disease (Crohn's disease or ulcerative proctitis), celiac disease, carcinoid syndrome, hereditary inheritance or intestinal obstruction
- •? If you have undergone gastrointestinal surgery other than gastrectomy (however, you can register for appendectomy, cholecystectomy and hernia surgery)
- •? Subjects whose mastication function has been lost
- •? Subjects with major psychiatric disorders (DSM-III or DSM-IV) that cannot be controlled by antidepressant drug therapy (however, those with mental illness are excluded regardless of current drug therapy)
- •? Subjects with a history of drug or alcohol abuse (within 12 months prior to screening)
- •? Subjects who have participated in drug or medical device research within 30 days prior to participation in the clinical trial
- •? Pregnant or lactating women (in the case of women of childbearing age, the urine pregnancy test result within 14 days prior to administration of the test drug must be negative, and registration is possible only when consenting to use an appropriate contraceptive method to prevent pregnancy)
- •? Subjects with chronically poor oral intake or persistent parenteral subjects, subjects with poor systemic conditions. However, temporary poor oral intake due to current disease is excluded.
- •? People with unstable systemic disease (active infection, serious cardiovascular disease [including myocardial infarction within 1 year], severe renal failure (Creatinine> 2.0 mg/dL), severe liver disease or metabolic disease, metabolic dysfunction (diabetes Etc.), except when factors prohibiting the use of clinical trial drugs are found in the results of physical examinations or clinical or diagnostic medical tests, or that may affect the interpretation of the results or cause the subject to be at risk due to complications of treatment.
- •? Subjects judged to be inappropriate according to the judgment of other examiners
研究者
相似试验
进行中（未招募）
1 期
Treatment of dumping syndrome with Lanreotide Autogeltreatment of the dumping syndrome with Lanreotide AutogelEUCTR2007-001078-94-NLRadboud University medical centre12
尚未招募
4 期
Treatment of dumping syndrome with Lanreotide AutogelDumping syndrome10018012NL-OMON31107niversitair Medisch Centrum Sint Radboud12
尚未招募
不适用
ymphatic Drainage and Taping in the treatment of edema in pregnant womeEdemaPregnancyC23.888RBR-4q3xpdtniversidade Federal da Paraíba
进行中（未招募）
1 期
Sandostatine LAR in Dumping syndrome - Dumping SyndromeDumping Syndrome is a condition characterized by weakness, dizziness, flushing and warmth, nausea and palpitation immediately or shortly after eating and produced by abnormally rapid emptying of the stomach in persons who have had part of the stomach removed or in hypersensitive or neurotic individualsEUCTR2005-003250-98-BEZ LEUVE
招募中
不适用
Development of diagnosis and treatment strategy for breast cancer based on molecular classificatioBreast Cancer and benign breast diseaseJPRN-UMIN000038962Hyogo College of Medicine2,100